News and Event Archive

Exco InTouch Wins Deloitte Technology Fast 50 Award in Recognition of Significant Growth

Posted by cwatson

Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, today announced that it is a winner of the 2011 Deloitte Technology Fast 50. The awards, now in their 14th year, are an independent ranking of the 50 fastest-growing technology companies in the UK, based on percentage growth in revenue over five years. Exco InTouch was placed as the 44th fastest growing company in the country and the 7th fastest growing company in the South East region. Receipt of the Fast 50 award is a significant achievement, recognising growth based on innovation and entrepreneurship. Exco InTouch’s win comes on the back of a recent growth investment from leading growth equity and venture capital group Scottish Equity Partners (SEP).

read full post

News Archive

Exco InTouch Success Stories - Testimonial

Follow us

InTouch Clinical - Secure and regulatory compliant mobile solutions automatically schedule and deliver text messages directly to patients and caregivers.

Secure & regulatory compliant mobile solutions which automatically schedule & deliver text messages to patient & caregiver cell phones

ePRO Cell - The world’s first validated eDiary solution on a mobile phone. Secure, smarter and easier to gather crucial PRO data.

The world’s first validated ePRO solution on a cell phone. A secure, smarter & easier method of collecting crucial PRO data

ePRO APP - A simpler, more efficient way to gather data from subjects, care givers and sites that is fast to set up and easy to use.

A simpler, more efficient way to gather PRO data from subjects, caregivers & sites, that is quick to set up & easy to use by all participants

InTouch Recruit - Enhancing recruitment into clinical trials allows sponsor companies to reduce time and ultimately to bring new drugs to market faster.

Enhancing clinical trials recruitment, allowing sponsor companies to reduce timelines & ultimately bring new drugs to market faster